BIOACTIVE SUBSTANCE

NEW MATERIAL:A bioactive substance MP-A produced by a Staphylococcus aureus and having the following properties; Molecular weight: 1X10 dalton(SDS- PAGE method), Bioactivity: significantly high activity of lymphocyte transformation to human peripheral blood mononuclear cyte, production of interleuki...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KOYAMAISHI YOSHIHIRO, MIZUKOSHI MIKIO, MIYAKOSHI HIDEO, SUGIMOTO MASAZUMI
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	NEW MATERIAL:A bioactive substance MP-A produced by a Staphylococcus aureus and having the following properties; Molecular weight: 1X10 dalton(SDS- PAGE method), Bioactivity: significantly high activity of lymphocyte transformation to human peripheral blood mononuclear cyte, production of interleukin-2, cytotoxicity and induction of IgG production, Solubility: soluble at >=pH4 and precipitate at